Lv6
3106 积分 2023-12-13 加入
Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan
4小时前
待确认
A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma
11小时前
待确认
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
8天前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
8天前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
14天前
已完结
A systematic literature review of MTAP deletions in solid and hematologic Cancers
20天前
已完结
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase I dose exploration
22天前
已完结
BMS-986504 in patients (pts) with advanced solid tumors with homozygous MTAP deletion ( MTAP -del): Clinical update and first report of pharmacokinetics (PK) and pharmacodynamic (PD) analyses from CA240-0007
22天前
已完结
A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial
22天前
已完结
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp
1个月前
已完结
皖公网安备34019202002308
